关于 flecainide 在 катехоламинергия 多态心室性心动减速症中的机制的见解
Ross Davidson1, Maria Medeiros1
1Department of Medicine, King's College Hospital, Denmark Hill, London.
Journal of medicine and life
|November 29, 2023
概括
弗莱卡尼德通过影响心脏的氨酸受体,有效地治疗catecholaminergic多形心室性心力衰竭 (CPVT). 这篇评论探讨了弗莱卡因尼德是否存在.
科学领域:
- 心脏病学 心脏病学
- 分子生物学分子生物学
- 药理学 药理学是指药理学的学科.
背景情况:
- catecholaminergic polymorphic ventricular tachycardia (CPVT) 是一种遗传性疾病,由于心脏细胞处理的错误,导致危险的心律.
- 这种情况与心脏氨酸受体 (RyR2) 的突变有关,导致压力期间异常释放.
- 弗莱卡尼德 (Flecainide) 是一种Class Ic类抗失常药,用于管理CPVT,但其精确的作用仍在争论中.
研究的目的:
- 批判性地评估弗莱卡尼德在治疗CPVT中的疗效的拟议机制.
- 讨论证据支持直接或间接的效应的flekainide对RyR2功能.
- 综合最近的发现,以澄清flekainide在CPVT中的治疗作用.
主要方法:
- 审查和分析现有的科学文献和关于弗莱卡尼德和CPVT的最新研究.
- 探讨对RyR2-介导的释放的直接影响.
- 检查涉及通道阻塞和动态的拟议间接影响.
主要成果:
- 有证据表明,flekainide可能通过多个途径发挥其抗心律失常作用.
- 通道阻塞在调节细胞内处理中的作用是研究的一个关键领域.
- 虽然提出了与RyR2的直接相互作用,但需要进一步阐明.
结论:
- 在CPVT治疗中,弗莱卡尼德的确切机制仍然很复杂,可能是多因素的.
- 需要进一步的研究来确定对RyR2的直接和间接影响之间的区别.
- 了解这些机制对于优化CPVT治疗至关重要.
相关概念视频
ECG Interpretation of Arrhythmias II: Atrial, Junctional and Ventricular Arrhythmias
21
Arrhythmia is a condition characterized by an irregular heart rhythm, with ECG changes that differ based on its origin and nature. The types of arrhythmias discussed below include atrial, junctional, and ventricular arrhythmias.Atrial ArrhythmiasPremature Atrial Complexes (PACs): PACs are early atrial beats caused by stress, caffeine, alcohol, electrolyte imbalances, hypoxia, hyperthyroidism, or certain medications (e.g., bronchodilators and decongestants). The ECG shows early P waves with an...
21
Antiarrhythmic Drugs: Class II Agents as β-Adrenergic Blockers
747
Adrenergic stimulation generally impacts cardiac rate and rhythm. Specifically, stimulation of the β-adrenoceptors triggers an increase in intracellular calcium ion influx and pacemaker currents, which may cause arrhythmias. Catecholamines like adrenaline also demonstrate β2-adrenoceptor-mediated hypokalemia, impacting cardiac action potential and disrupting the normal cardiac rhythm. Class II antiarrhythmic drugs are β-adrenoceptor antagonists or β-blockers, which...
747
Mechanism of Cardiac Arrhythmias
925
Arrhythmias are irregular heart rhythms occurring when the heart's electrical impulses become abnormal. These disturbances can lead to various symptoms, depending on their severity and the underlying cause. Some common factors contributing to arrhythmias include hypoxia, ischemia, electrolyte imbalances, excessive catecholamine exposure, drug toxicity, and muscle overstretching. Arrhythmias can be classified into two main types based on the rate and site of origin of abnormal heart rhythms.
925
Antiarrhythmic Drugs: Class IV Agents as Calcium Channel Blockers
845
Class IV antiarrhythmic drugs, such as verapamil and diltiazem, block calcium channels. They primarily affect the heart, slowing the conduction in calcium-dependent tissues like the SA and AV nodes. These drugs manage reentrant supraventricular tachycardia (SVT) and reduce ventricular rate in atrial flutter/fibrillation.
Verapamil, a calcium channel blocker, inhibits calcium movement across myocardial cell membranes and vascular smooth muscle. This results in the dilation of coronary and...
Verapamil, a calcium channel blocker, inhibits calcium movement across myocardial cell membranes and vascular smooth muscle. This results in the dilation of coronary and...
845
Disturbances in Heart Rhythm
972
Arrhythmia or dysrhythmia refers to an abnormal heart rhythm caused by a defect in the heart's conduction system. It can cause the heart to beat irregularly, too quickly, or too slowly, leading to symptoms like chest pain, shortness of breath, and fainting. Factors such as stress, caffeine, alcohol, nicotine, cocaine, certain drugs, congenital defects, diseases, and electrolyte abnormalities can trigger arrhythmias.
Arrhythmias are categorized by their speed, rhythm, and origin. A slow...
Arrhythmias are categorized by their speed, rhythm, and origin. A slow...
972
Antiarrhythmic Drugs: Class III Agents as Potassium Channel Blockers
1.0K
Class III antiarrhythmic drugs are a group of medications that can prolong action potentials in the heart. They achieve this by blocking potassium channels or enhancing inward currents from sodium channels. However, these drugs have a unique property of "reverse use-dependence," which is most pronounced at slower heart rates and can lead to torsades de pointes—a specific type of arrhythmia. However, it is essential to note that excessive QT interval prolongation—a measure of...
1.0K


